Company Novamed Srl with Fiscal Code 15737109
recorded a turnover of 2024 of
170.830,
with a net profit of
125.151
and having an average number of employees of
2.
The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Novamed Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
-
32.435
50.120
62.546
76.501
88.189
106.816
133.154
162.140
170.830
Total Income - EUR
-
32.435
50.120
62.552
76.502
88.190
109.850
133.186
162.141
170.831
Total Expenses - EUR
-
8.784
11.937
12.073
13.303
19.967
26.262
28.544
30.151
40.914
Gross Profit/Loss - EUR
-
23.651
38.183
50.479
63.199
68.223
83.588
104.643
131.990
129.917
Net Profit/Loss - EUR
-
23.003
37.595
49.853
62.434
67.408
82.519
103.311
130.369
125.151
Employees
-
2
2
2
2
2
2
2
2
2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 6.0%, from 162.140 euro in the year 2023, to 170.830 euro in 2024.
The Net Profit decreased by -4.489 euro, from 130.369 euro in 2023, to 125.151 in the last year.
Check the financial reports for the company - Novamed Srl
Financial Rating - NOVAMED SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Novamed Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Novamed Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Novamed Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
126.035 euro in 2024 which includes Inventories of
0 euro, Receivables of
121.251 euro and cash availability of
4.784 euro.
The company's Equity was valued at
125.201 euro, while total Liabilities amounted to
25.561 euro.
Equity decreased by -4.489 euro, from 130.418 euro in 2023, to 125.201 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Novamed Srl